Sustainability at Abbott
At Abbott, sustainability means managing our company to deliver long-term impact for the people we serve – shaping the future of healthcare and helping the greatest number of people live better and healthier.
BMAC – Biopharmaceutical Manufacturer's Advisory Council
An initiative by leading Biopharmaceutical companies in the world to establish Singapore as the country of choice for global biomedical sciences manufacturing.
At Abbott, sustainability means managing our company to deliver long-term impact for the people we serve – shaping the future of healthcare and helping the greatest number of people live better and healthier.
Sanofi Jurong Singapore is working to minimize the impact of our activities and medicines on the environment, through our Planet Care environmental sustainability program.
Taking in the wonders of nature, our colleagues enjoyed a morning hike at the Dairy Farm Nature Park.
Good physical health is closely linked to improved mental well-being. Here, our colleagues participated in some heart-pumping kickboxing, to stay fit and build camaraderie with one another!
Kaneka Corporation (Headquarters: Minato-ku, Tokyo; President: Minoru Tanaka) will manufacture and supply intermediates to Shionogi & Co., Ltd. (Headquarters: Chuo-ku,Osaka; Chief Executive Officer: Isao Teshirogi, Ph.D.) for use in Xocova®*1 (EnsitrelvirFumaric Acid) Tablets 125mg, a drug for the treatment of SARS-Cov-2 infection.
Kaneka Corporation (Headquarters: Minato-ku, Tokyo; President: Minoru Tanaka) has received authorization for the manufacture and sale of “Kaneka Immunochromatography SARS-CoV-2 Ag,” a COVID-19 antigen test kit, and launched the new in-vitro diagnostic agent on June 15. The kit has a suggested retail price of 13,200 yen (for 10 tests), including tax.
Test kit capable of detecting both types of Omicron variants with a single PCR test
Did you know you know that 2.2 billion people around the world suffer from impaired vision? Or that almost half of these cases of vision loss could have been prevented or are yet to be addressed?
High Blood Cholesterol is amongst the top three non-communicable diseases (NCDs) , and has the highest prevalence compared to diabetes and high blood pressure.
Leqvio® (inclisiran) is an innovative medicine that can change how low-density lipoprotein cholesterol (LDL-C) or commonly known as bad cholesterol is treated.